North America Radiation Oncology Market Forecast to 2031 - Regional Analysis

Description

List of Tables

The North America radiation oncology market was valued at US$ 4,047.23 million in 2023 and is expected to reach US$ 10,409.58 million by 2031; it is estimated to record a CAGR of 12.5% from 2023 to 2031.

Increasing Prevalence of Cancer Fuels North America Radiation Oncology Market

Cancer is one of the common health conditions significantly impacting society worldwide. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, accounting for 9.7 million deaths and 20 million new cancer cases in 2023 and it is expected to reach ~35 million new cancer cases by 2050. As per the WHO 2024 report, lung cancer is the most common cancer and leading cause of the death globally followed by colorectal cancer, liver cancer, breast cancer, and stomach cancer accounting for 18.7%, 9.3%, 7.8%, 6.9%, and 6.8% of the total deaths respectively.

The increasing prevalence and incidence of cancer creates demand for effective treatment options. Radiotherapy is one of evolving treatment options for cancer patients with effective outcome which utilizes the high doses of radiation such as X-rays, gamma rays, and others to kill the cancerous cells. Radiotherapy is used in the early stages of cancer and various types of external beam radiotherapy are used for the treatment of different cancers. For instance, brachytherapy is used for the treatment of breast cancer, cervix cancer, eye cancer, prostate cancer, and head & neck cancer. Similarly, Systemic radiation therapy is also known as radioactive iodine and is used for treatment of thyroid cancer. Radiation therapy can be used at any point in the treatment and can be combined with other treatments such as surgery, chemotherapy, immunotherapy and others. Therefore, increasing prevalence of cancer and evolution of radiotherapy in oncology is expected to drive the growth of radiation oncology market.

North America Radiation Oncology Market Overview

Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2023, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy.

North America Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

North America Radiation Oncology Market Segmentation

The North America radiation oncology market is categorized into types, application, and country.

Based on types, the North America radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the North America radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the North America radiation oncology market is segmented into the US, Canada, and Mexico. The US dominated the North America radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, and Curium are some of the leading companies operating in the North America radiation oncology market.

Product Code: BMIRE00031021

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Radiation Oncology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. North America Radiation Oncology Market - Key Market Dynamics

5.1 Market Drivers:
- 5.1.1 Increasing Prevalence of Cancer
- 5.1.2 Initiatives to Support Developments in Radiation Oncology
5.2 Market Restraints
- 5.2.1 High Cost of Radiotherapy Equipment
5.3 Market Opportunities
- 5.3.1 Strategic Initiatives in Radiation Oncology
5.4 Future Trends
- 5.4.1 Technological Advancement in Radiation Oncology
5.5 Impact of Drivers and Restraints:

6. Radiation Oncology Market - North America Market Analysis

6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

7. North America Radiation Oncology Market Analysis - by Types

7.1 External Beam Radiation Therapy
- 7.1.1 Overview
- 7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
- 7.2.1 Overview
- 7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Radiation Oncology Market Analysis - by Application

8.1 Breast Cancer
- 8.1.1 Overview
- 8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
- 8.2.1 Overview
- 8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
- 8.3.1 Overview
- 8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Head and Neck Cancer
- 8.4.1 Overview
- 8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
- 8.5.1 Overview
- 8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Radiation Oncology Market - Country Analysis

9.1 North America Radiation Oncology Market Overview
- 9.1.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.1.1 United States: Radiation Oncology Market Breakdown, by Types
    - 9.1.1.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.1.1.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.1.1.1.4 United States: Radiation Oncology Market Breakdown, by Application
  - 9.1.1.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.2.1 Canada: Radiation Oncology Market Breakdown, by Types
    - 9.1.1.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.1.1.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.1.1.2.4 Canada: Radiation Oncology Market Breakdown, by Application
  - 9.1.1.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
    - 9.1.1.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
    - 9.1.1.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
    - 9.1.1.3.4 Mexico: Radiation Oncology Market Breakdown, by Application

10. Radiation Oncology Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Radiation Oncology Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Varian Medical Systems Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Elekta AB
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Accuray Incorporated
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 IBA Worldwide (Ion Beam Applications SA)
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Becton Dickinson and Co
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Perspective Therapeutics Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 NTP RADIOISOTOPES
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Mallinckrodt Plc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Provision Healthcare
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Curium
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms